Avidity Partners Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$580K	Sell	25,934 -80,966	-76%	-$1.93M	0.06%	49
2025 Q4	$2.86M	Sell	106,900 -37,100	-26%	-$887K	0.82%	27
2025 Q3	$3.07M	Buy	+144,000	New	+$3.41M	0.7%	32
2025 Q2	–	Sell	-169,000	Closed	-$2.81M	–	57
2025 Q1	$2.81M	Buy	+169,000	New	+$3.07M	0.58%	48
2024 Q2	–	Sell	-588,500	Closed	-$10.9M	–	86
2024 Q1	$10.9M	Buy	+588,500	New	+$14.6M	0.39%	71
2022 Q1	–	Sell	-300,000	Closed	-$7M	–	93
2021 Q4	$7M	Sell	300,000 -250,000	-45%	-$5.03M	0.15%	67
2021 Q3	$9.14M	Sell	550,000 -390,000	-41%	-$7.52M	0.23%	72
2021 Q2	$22.9M	Buy	+940,000	New	+$21.2M	0.62%	49
2021 Q1	–	Sell	-527,600	Closed	-$28.2M	–	95
2020 Q4	$28.2M	Buy	+527,600	New	+$26.2M	0.95%	40
2020 Q2	–	Sell	-357,000	Closed	-$15.1M	–	58
2020 Q1	$15.1M	Buy	357,000 +303,000	+561%	+$12.5M	2.16%	17
2019 Q4	$2.31M	Buy	+54,000	New	+$2.35M	1.46%	28